ClinConnect ClinConnect Logo
Search / Trial NCT06341491

The Study of Delay Discounting Among Beneficiaries of the Pé-de-Meia Program

Launched by FEDERAL INSTITUTE OF EDUCATION, SCIENCE AND TECHNOLOGY OF THE STATE OF MATO GROSSO · Mar 25, 2024

Trial Information

Current as of July 05, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how a program called "Pé-de-Meia" impacts high school students from low-income families in Brazil. The program aims to help these students stay in school and complete their studies. The researchers want to understand if this program influences the students' ability to wait for a reward, which is known as "delay discounting." In simpler terms, they are exploring whether students who participate in this program are better at making long-term decisions and how this might relate to their school performance and attendance.

To be eligible for this study, students must be enrolled in public high schools and come from low-income families. However, students with a psychological or psychiatric diagnosis will not be included. If selected to participate, students will take part in assessments to measure their decision-making skills and their academic results will be tracked over time. This research aims to shed light on how support programs like "Pé-de-Meia" can benefit students' education and future choices.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • High school students, Students from public schools; Students from low-income families. -
  • Exclusion Criteria:
  • Students with a formal psychological report; students with a formal psychiatric report.
  • -

About Federal Institute Of Education, Science And Technology Of The State Of Mato Grosso

The Federal Institute of Education, Science and Technology of the State of Mato Grosso (IFMT) is a prominent educational and research institution dedicated to advancing knowledge and innovation in the fields of education and technology. Committed to fostering scientific research and development, IFMT actively engages in clinical trials aimed at improving public health outcomes and enhancing community well-being. With a focus on collaboration and ethical standards, the institute leverages its academic expertise and resources to contribute to the advancement of medical science, ensuring rigorous methodologies and impactful findings that benefit both local and broader populations.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported